Drug intelligence / Profile preview

Bronchicum Tropfen

Development stage
Phase 4
Lead developer
MCM Klosterfrau
Modality
Small Molecules
Administration
Oral
01

Overview

Bronchicum Tropfen is a traditional herbal medicinal product used to improve symptoms of acute bronchitis and respiratory colds characterized by viscous mucus. It is a combination of liquid extracts from thyme herb (*Thymus vulgaris* or *Thymus zygis*) and primula root (*Primula veris* or *Primula elatior*). Thyme provides secretolytic, bronchospasmolytic, and antibacterial properties, primarily through its essential oil components like thymol and carvacrol, which interact with TRP channels and GABA receptors. Primula root contains saponins that act as expectorants by stimulating the gastric mucosa, which reflexively increases bronchial secretions. The product is marketed by MCM Klosterfrau and is frequently used as a standard-of-care comparator in clinical trials for herbal cough treatments.

Brand names
Bronchicum Tropfen
Other names
Bronchicum drops
02

Targets

GABRR (GABA-A receptor subunit rho)TRPA1 (Transient receptor potential cation channel subfamily A member 1)TRPV3 (Transient receptor potential vanilloid subtype 3)GABA-B (Gamma-aminobutyric acid receptor type B)

Beyond the preview

Go deeper on Bronchicum Tropfen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bronchicum Tropfen.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call